New agents effectively target CLL’s molecular AchillesDecember 18, 2015Leukemia, Myelodysplasia, Transplantation
Cancer incidence higher in men, blacksDecember 18, 2015Preventive CarePractice ManagementBreast Cancer
More complete cytogenetic responses at 12 months with radotinib than imatinibDecember 18, 2015Leukemia, Myelodysplasia, Transplantation
Nilotinib safe, effective as first-line therapy for CML-CP patients age 65 and olderDecember 18, 2015Leukemia, Myelodysplasia, Transplantation
Tumor-treating fields may improve outcomes in glioblastomaDecember 18, 2015CNS/Brain CancerNeuro-oncology
ASH: First shot across the bow for CAR T cells in multiple myelomaDecember 17, 2015Lymphoma & Plasma Cell Disorders
Anti-BCL2, CD20 combo safe, effective in untreated CLLDecember 17, 2015Leukemia, Myelodysplasia, Transplantation
TH3RESA: T-DM1 prolongs survival in heavily pretreated HER2-positive breast cancerDecember 17, 2015Breast Cancer